Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2003;93:414-420
Published online before print July 31, 2003, doi: 10.1161/01.RES.0000089460.12061.E1
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
93/5/414    most recent
01.RES.0000089460.12061.E1v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dell’Era, P.
Right arrow Articles by Presta, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dell’Era, P.
Right arrow Articles by Presta, M.
Related Collections
Right arrow Physiological and pathological control of gene expression
Right arrow Cardiac development
(Circulation Research. 2003;93:414.)
© 2003 American Heart Association, Inc.


Molecular Medicine

Fibroblast Growth Factor Receptor-1 Is Essential for In Vitro Cardiomyocyte Development

Patrizia Dell’Era, Roberto Ronca, Laura Coco, Stefania Nicoli, Marco Metra, Marco Presta

From the Unit of General Pathology and Immunology, Department of Biomedical Sciences and Biotechnology (P.D.E., R.R., L.C., S.N., M.P.) and the Department of Experimental and Applied Medicine (M.M.), University of Brescia, Brescia, Italy.

Correspondence to Marco Presta, Unit of General Pathology and Immunology, Department of Biomedical Sciences and Biotechnology, University of Brescia, Via Valsabbina 19, 25123 Brescia, Italy. E-mail presta{at}med.unibs.it

Fibroblast growth factor (FGF)/FGF receptor (FGFR) signaling plays a crucial role in mesoderm formation and patterning. Heartless mutant studies in Drosophila suggest that FGFR1, among the different FGFRs, may play a role in cardiogenesis. However, fgfr1-/- mice die during gastrulation before heart formation. To establish the contribution of FGFR1 in cardiac development, we investigated the capacity of murine fgfr1+/- and fgfr1-/- embryonic stem (ES) cells to differentiate to cardiomyocytes in vitro. Clusters of pulsating cardiomyocytes were observed in >90% of 3-dimensional embryoid bodies (EBs) originated from fgfr1+/- ES cells at day 9 to 10 of differentiation. In contrast, 10% or less of fgfr1-/- EBs showed beating foci at day 16. Accordingly, fgfr1-/- EBs were characterized by impaired expression of early cardiac transcription factors Nkx2.5 and d-Hand and of late structural cardiac genes myosin heavy chain (MHC)-{alpha}, MHC-ß, and ventricular myosin light chain. Homozygous fgfr1 mutation resulted also in alterations of the expression of mesoderm-related early genes, including nodal, BMP2, BMP4, T(bra), and sonic hedgehog. Nevertheless, fgfr1+/- and fgfr1-/- EBs similarly express cardiogenic precursor, endothelial, hematopoietic, and skeletal muscle markers, indicating that fgfr1-null mutation exerts a selective effect on cardiomyocyte development in differentiating ES cells. Accordingly, inhibitors of FGFR signaling, including the FGFR1 tyrosine kinase inhibitor SU 5402, the MEK1/2 inhibitor U0126, and the protein kinase C inhibitor GF109 all prevented cardiomyocyte differentiation in fgfr1+/- EBs without affecting the expression of the hematopoietic/endothelial marker flk-1. In conclusion, the data point to a nonredundant role for FGFR1-mediated signaling in cardiomyocyte development.


Key Words: fibroblast growth factor receptor • cardiomyocytes • embryonic stem cells




This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
H. Sadek, B. Hannack, E. Choe, J. Wang, S. Latif, M. G. Garry, D. J. Garry, J. Longgood, D. E. Frantz, E. N. Olson, et al.
Cardiogenic small molecules that enhance myocardial repair by stem cells
PNAS, April 22, 2008; 105(16): 6063 - 6068.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
P. U. Magnusson, A. Dimberg, S. Mellberg, A. Lukinius, and L. Claesson-Welsh
FGFR-1 regulates angiogenesis through cytokines interleukin-4 and pleiotrophin
Blood, December 15, 2007; 110(13): 4214 - 4222.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
S. Ueno, G. Weidinger, T. Osugi, A. D. Kohn, J. L. Golob, L. Pabon, H. Reinecke, R. T. Moon, and C. E. Murry
From the Cover: Biphasic role for Wnt/beta-catenin signaling in cardiac specification in zebrafish and embryonic stem cells
PNAS, June 5, 2007; 104(23): 9685 - 9690.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
B. A. Pallante, I. Duignan, D. Okin, A. Chin, M. C. Bressan, T. Mikawa, and J. M. Edelberg
Bone Marrow Oct3/4+ Cells Differentiate Into Cardiac Myocytes via Age-Dependent Paracrine Mechanisms
Circ. Res., January 5, 2007; 100(1): e1 - e11.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
A. Norstrom, K. Akesson, T. Hardarson, L. Hamberger, P. Bjorquist, and P. Sartipy
Molecular and Pharmacological Properties of Human Embryonic Stem Cell-Derived Cardiomyocytes
Experimental Biology and Medicine, December 1, 2006; 231(11): 1753 - 1762.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
M. Nemir, A. Croquelois, T. Pedrazzini, and F. Radtke
Induction of Cardiogenesis in Embryonic Stem Cells via Downregulation of Notch1 Signaling
Circ. Res., June 23, 2006; 98(12): 1471 - 1478.
[Abstract] [Full Text] [PDF]


Home page
PhysiologyHome page
S. P. Raikwar, T. Mueller, and N. Zavazava
Strategies for Developing Therapeutic Application of Human Embryonic Stem Cells
Physiology, February 1, 2006; 21(1): 19 - 28.
[Abstract] [Full Text] [PDF]


Home page
Microbiol. Mol. Biol. Rev.Home page
L. Yuan, I. Kurek, J. English, and R. Keenan
Laboratory-Directed Protein Evolution
Microbiol. Mol. Biol. Rev., September 1, 2005; 69(3): 373 - 392.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
G. D. Zheng, K. Hidaka, and T. Morisaki
Stable and Uniform Gene Suppression by Site-Specific Integration of siRNA Expression Cassette in Murine Embryonic Stem Cells
Stem Cells, September 1, 2005; 23(8): 1028 - 1034.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
G. Keller
Embryonic stem cell differentiation: emergence of a new era in biology and medicine
Genes & Dev., May 15, 2005; 19(10): 1129 - 1155.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
V. W.M. van Hinsbergh and T. J. Rabelink
FGFR1 and the Bloodline of the Vasculature
Arterioscler. Thromb. Vasc. Biol., May 1, 2005; 25(5): 883 - 886.
[Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
C. A. Nichols and T. L. Creazzo
L-type Ca2+ channel function in the avian embryonic heart after cardiac neural crest ablation
Am J Physiol Heart Circ Physiol, March 1, 2005; 288(3): H1173 - H1178.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
T. Rothhammer, I. Poser, F. Soncin, F. Bataille, M. Moser, and A.-K. Bosserhoff
Bone Morphogenic Proteins Are Overexpressed in Malignant Melanoma and Promote Cell Invasion and Migration
Cancer Res., January 15, 2005; 65(2): 448 - 456.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
D. Rudy-Reil and J. Lough
Avian Precardiac Endoderm/Mesoderm Induces Cardiac Myocyte Differentiation in Murine Embryonic Stem Cells
Circ. Res., June 25, 2004; 94(12): e107 - e116.
[Abstract] [Full Text] [PDF]